8TI Fundamental Analysis - STELLANTIS NV

Fundamental Rating

8TI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 32 industry peers in the Automobiles industry. 8TI has a bad profitability rating. Also its financial health evaluation is rather negative. 8TI has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year 8TI has reported negative net income.

8TI had a negative operating cash flow in the past year.

In the past 5 years 8TI has always been profitable.

Each year in the past 5 years 8TI had a positive operating cash flow.

1.2 Ratios

With a Return On Assets value of -1.19%, 8TI is not doing good in the industry: 68.97% of the companies in the same industry are doing better.

8TI's Return On Equity of -3.27% is on the low side compared to the rest of the industry. 8TI is outperformed by 68.97% of its industry peers.

		Industry Rank	Sector Rank
ROA	-1.19%
ROE	-3.27%
ROIC	N/A

ROA(3y)6.95%

ROA(5y)5.83%

ROE(3y)17.6%

ROE(5y)15.66%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

8TI's Profit Margin has declined in the last couple of years.

In the last couple of years the Operating Margin of 8TI has declined.

8TI has a worse Gross Margin (7.74%) than 86.21% of its industry peers.

8TI's Gross Margin has been stable in the last couple of years.

8TI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	7.74%

OM growth 3Y-28.95%

OM growth 5Y-7.06%

PM growth 3Y-28.4%

PM growth 5Y-10.63%

GM growth 3Y-13.66%

GM growth 5Y-1.49%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

8TI does not have a ROIC to compare to the WACC, probably because it is not profitable.

8TI has less shares outstanding than it did 1 year ago.

8TI has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, 8TI has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.33, we must say that 8TI is in the distress zone and has some risk of bankruptcy.

The Altman-Z score of 8TI (1.33) is better than 62.07% of its industry peers.

8TI has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.

The Debt to Equity ratio of 8TI (0.38) is better than 68.97% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.38
Debt/FCF	N/A
Altman-Z	1.33

ROIC/WACCN/A

WACC6.96%

2.3 Liquidity

8TI has a Current Ratio of 1.06. This is a normal value and indicates that 8TI is financially healthy and should not expect problems in meeting its short term obligations.

8TI has a worse Current ratio (1.06) than 72.41% of its industry peers.

8TI has a Quick Ratio of 1.06. This is a bad value and indicates that 8TI is not financially healthy enough and could expect problems in meeting its short term obligations.

8TI has a Quick ratio of 0.77. This is in the lower half of the industry: 8TI underperforms 72.41% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.06
Quick Ratio	0.77

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for 8TI have decreased strongly by -118.93% in the last year.

Measured over the past years, 8TI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -15.26% on average per year.

Looking at the last year, 8TI shows a very negative growth in Revenue. The Revenue has decreased by -17.07% in the last year.

8TI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.72% yearly.

EPS 1Y (TTM)-118.93%

EPS 3Y-25.78%

EPS 5Y-15.26%

EPS Q2Q%-141.95%

Revenue 1Y (TTM)-17.07%

Revenue growth 3Y1.64%

Revenue growth 5Y7.72%

Sales Q2Q%71.49%

3.2 Future

8TI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.95% yearly.

Based on estimates for the next years, 8TI will show a small growth in Revenue. The Revenue will grow by 3.64% on average per year.

EPS Next Y-83%

EPS Next 2Y-16.54%

EPS Next 3Y-1.94%

EPS Next 5Y13.95%

Revenue Next Year-2.53%

Revenue Next 2Y1.18%

Revenue Next 3Y1.94%

Revenue Next 5Y3.64%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

8TI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

8TI is valuated cheaply with a Price/Forward Earnings ratio of 5.00.

Based on the Price/Forward Earnings ratio, 8TI is valued a bit cheaper than the industry average as 75.86% of the companies are valued more expensively.

The average S&P500 Price/Forward Earnings ratio is at 23.05. 8TI is valued rather cheaply when compared to this.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	5

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 8TI is valued a bit cheaper than the industry average as 62.07% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	6.23

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-16.54%

EPS Next 3Y-1.94%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for 8TI!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

STELLANTIS NV

FRA:8TI (9/26/2025, 7:00:00 PM)

7.919

-0.07 (-0.89%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupAutomobiles & Components

GICS IndustryAutomobiles

Earnings (Last)07-21 2025-07-21/bmo

Earnings (Next)10-30 2025-10-30

Inst Owners50.06%

Inst Owner ChangeN/A

Ins Owners0.12%

Ins Owner ChangeN/A

Market Cap22.93B

Analysts67.65

Price Target9.29 (17.31%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend1.58

Dividend Growth(5Y)0.29%

DP-81.93%

Div Incr Years2

Div Non Decr Years2

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-2.09%

PT rev (3m)-14.19%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)-47.48%

EPS NY rev (3m)-81.29%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-0.02%

Revenue NY rev (3m)-3.19%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	5
P/S	0.16
P/FCF	N/A
P/OCF	N/A
P/B	0.31
P/tB	0.98
EV/EBITDA	6.23

EPS(TTM)-0.83

EYN/A

EPS(NY)1.58

Fwd EY20.01%

FCF(TTM)-4.68

FCFYN/A

OCF(TTM)-1.05

OCFYN/A

SpS50.46

BVpS25.25

TBVpS8.06

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-1.19%
ROE	-3.27%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	7.74%
FCFM	N/A

ROA(3y)6.95%

ROA(5y)5.83%

ROE(3y)17.6%

ROE(5y)15.66%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)13.77%

ROCE(5y)12.77%

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3Y-28.95%

OM growth 5Y-7.06%

PM growth 3Y-28.4%

PM growth 5Y-10.63%

GM growth 3Y-13.66%

GM growth 5Y-1.49%

F-Score1

Asset Turnover0.73

Health

		Industry Rank	Sector Rank
Debt/Equity	0.38
Debt/FCF	N/A
Debt/EBITDA	5.91
Cap/Depr	145.84%
Cap/Sales	7.2%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.06
Quick Ratio	0.77
Altman-Z	1.33

F-Score1

WACC6.96%

ROIC/WACCN/A

Cap/Depr(3y)140.23%

Cap/Depr(5y)152.03%

Cap/Sales(3y)5.82%

Cap/Sales(5y)6.83%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-118.93%

EPS 3Y-25.78%

EPS 5Y-15.26%

EPS Q2Q%-141.95%

EPS Next Y-83%

EPS Next 2Y-16.54%

EPS Next 3Y-1.94%

EPS Next 5Y13.95%

Revenue 1Y (TTM)-17.07%

Revenue growth 3Y1.64%

Revenue growth 5Y7.72%

Sales Q2Q%71.49%

Revenue Next Year-2.53%

Revenue Next 2Y1.18%

Revenue Next 3Y1.94%

Revenue Next 5Y3.64%

EBIT growth 1Y-114.76%

EBIT growth 3Y-27.78%

EBIT growth 5Y0.11%

EBIT Next Year17.69%

EBIT Next 3Y26.55%

EBIT Next 5Y23.17%

FCF growth 1Y-193.77%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-112.94%

OCF growth 3Y-40.45%

OCF growth 5Y-18.8%

STELLANTIS NV (8TI.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens